Abstract
Paronychia refers to the inflammation and/or infection of the nail folds. It occurs in to forms commonly: acute paronychia and chronic paronychia. Both forms are caused by a disruption of the normal seals of the nail apparatus. The disruption of the seals in the nail apparatus is commonly caused by irritants, contactants, as wells as repetitive trauma from manicures. Acute paronychia often demonstrates a distinct collection of pus or abscess formation within a nail fold. The most common cause of acute paronychia is Staphylococcus aureus. It may also be caused by other organisms including methicillin resistant Staphylococcus aureus. Chronic paronychia refers to paronychia that lasts more than 6 weeks. The treatments for acute and chronic paronychia are distinct. Chronic paronychia is considered to be an inflammatory process, although there can be secondary colonization by Candida and hypersensitivity to Candida may play a role in persistence and exacerbation of the process.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Daniel CR 3rd, Tosti A, Iorizzo M, Piraccini BM. The nail and Koebner-like phenomenon. Int J Dermatol. 2006;45(11):1372–3. https://doi.org/10.1111/j.1365-4632.2006.02958.x.
Daniel CR 3rd, Daniel MP, Daniel J, Sullivan S, Bell FE. Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen. Cutis. 2004;73(1):81–5.
Shemer A, Daniel CR 3rd. Common nail disorders. Clin Dermatol. 2013;31(5):578–86. https://doi.org/10.1016/j.clindermatol.2013.06.015.
Bahunuthula RK, Thappa DM, Kumari R, Singh R, Munisamy M, Parija SC. Evaluation of role of Candida in patients with chronic paronychia. Indian J Dermatol Venereol Leprol. 2015;81(5):485–90. https://doi.org/10.4103/0378-6323.158635.
Tosti A, Guerra L, Morelli R, Bardazzi F, Fanti PA. Role of foods in the pathogenesis of chronic paronychia. J Am Acad Dermatol. 1992;27(5 Pt 1):706–10.
Gorva AD, Mohil R, Srinivasan MS. Aggressive digital papillary adenocarcinoma presenting as a paronychia of the finger. J Hand Surg. 2005;30(5):534. https://doi.org/10.1016/j.jhsb.2005.01.011.
Kuschner SH, Lane CS. Squamous cell carcinoma of the perionychium. Bulletin. 1997;56(2):111–2.
Ko JH, Young A, Wang KH. Paronychia-like digital cutaneous metastasis. Br J Dermatol. 2014;171(3):663–5. https://doi.org/10.1111/bjd.13025.
Giacomel J, Lallas A, Zalaudek I, Argenziano G. Periungual Bowen disease mimicking chronic paronychia and diagnosed by dermoscopy. J Am Acad Dermatol. 2014;71(3):e65–7. https://doi.org/10.1016/j.jaad.2014.01.894.
Fung V, Sainsbury DC, Seukeran DC, Allison KP. Squamous cell carcinoma of the finger masquerading as paronychia. J Plast Reconstr Aesthet Surg JPRAS. 2010;63(2):e191–2. https://doi.org/10.1016/j.bjps.2009.02.091.
Lovett JE, Haines TA, Bentz ML, Shestak KC, Flynn KJ, Kapadia SB. Subungual keratoacanthoma masquerading as a chronic paronychia. Ann Plast Surg. 1995;34(1):84–7.
High DA, Luscombe HA, Kauh YC. Leukemia cutis masquerading as chronic paronychia. Int J Dermatol. 1985;24(9):595–7.
Betti R, Vergani R, Inselvini E, Tolomio E, Crosti C. Guess what! Subungual squamous cell carcinoma mimicking chronic paronychia. Eur J Dermatol EJD. 2000;10(2):149–50.
Shepherd DM, Dzikowski CM, Chussid F. Bronchogenic carcinoma mimicking paronychia and osteomyelitis in the great toe. J Foot Ankle Surg Off Publ Am Coll Foot Ankle Surg. 1997;36(2):115–9.
Cohen PR, Buzdar AU. Metastatic breast carcinoma mimicking an acute paronychia of the great toe: case report and review of subungual metastases. Am J Clin Oncol. 1993;16(1):86–91.
Rockwell PG. Acute and chronic paronychia. Am Fam Physician. 2001;63(6):1113–6.
Ritting AW, O’Malley MP, Rodner CM. Acute paronychia. J Hand Surg. 2012;37(5):1068–70; quiz page 70. https://doi.org/10.1016/j.jhsa.2011.11.021.
Whitehead SM, Eykyn SJ, Phillips I. Anaerobic paronychia. Br J Surg. 1981;68(6):420–2.
Shafritz AB, Coppage JM. Acute and chronic paronychia of the hand. J Am Acad Orthop Surg. 2014;22(3):165–74. https://doi.org/10.5435/JAAOS-22-03-165.
Jebson PJ. Infections of the fingertip. Paronychias and felons. Hand Clin. 1998;14(4):547–55. viii.
Daniel CR 3rd. Paronychia. Dermatol Clin. 1985;3(3):461–4.
Brook I. Aerobic and anaerobic microbiology of paronychia. Ann Emerg Med. 1990;19(9):994–6.
Brook I. Paronychia: a mixed infection. Microbiology and management. J Hand Surg. 1993;18(3):358–9.
Tosti R, Samuelsen BT, Bender S, Fowler JR, Gaughan J, Schaffer AA, et al. Emerging multidrug resistance of methicillin-resistant Staphylococcus aureus in hand infections. J Bone Joint Surg Am. 2014;96(18):1535–40. https://doi.org/10.2106/JBJS.M.01159.
Rigopoulos D, Larios G, Gregoriou S, Alevizos A. Acute and chronic paronychia. Am Fam Physician. 2008;77(3):339–46.
Tosti R, Ilyas AM. Empiric antibiotics for acute infections of the hand. J Hand Surg. 2010;35(1):125–8. https://doi.org/10.1016/j.jhsa.2009.10.024.
Kirkland EB, Adams BB. Methicillin-resistant Staphylococcus aureus and athletes. J Am Acad Dermatol. 2008;59(3):494–502. https://doi.org/10.1016/j.jaad.2008.04.016.
Elston DM. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus: management principles and selection of antibiotic therapy. Dermatol Clin. 2007;25(2):157–64, vi. https://doi.org/10.1016/j.det.2007.01.007.
Elston DM. Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol. 2007;56(1):1–16; quiz 7–20. https://doi.org/10.1016/j.jaad.2006.04.018.
Wollina U. Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid. J Eur Acad Dermatol Venereol JEADV. 2001;15(1):82–4.
Daniel CR 3rd, Daniel MP, Daniel CM, Sullivan S, Ellis G. Chronic paronychia and onycholysis: a thirteen-year experience. Cutis. 1996;58(6):397–401.
Baran R. Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects. Clin Exp Dermatol. 1986;11(2):148–52.
Blumental G. Paronychia and pyogenic granuloma-like lesions with isotretinoin. J Am Acad Dermatol. 1984;10(4):677–8.
Zerboni R, Angius AG, Cusini M, Tarantini G, Carminati G. Lamivudine-induced paronychia. Lancet. 1998;351(9111):1256. https://doi.org/10.1016/S0140-6736(05)79324-7.
Colson AE, Sax PE, Keller MJ, Turk BK, Pettus PT, Platt R, et al. Paronychia in association with indinavir treatment. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32(1):140–3. https://doi.org/10.1086/317546.
Chanprapaph K, Vachiramon V, Rattanakaemakorn P. Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management. Dermatol Res Pract. 2014;2014:734249. https://doi.org/10.1155/2014/734249.
Giusti RM, Shastri KA, Cohen MH, Keegan P, Pazdur R. FDA drug approval summary: panitumumab (Vectibix). Oncologist. 2007;12(5):577–83. https://doi.org/10.1634/theoncologist.12-5-577.
Seiden MV, Burris HA, Matulonis U, Hall JB, Armstrong DK, Speyer J, et al. A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum- resistant ovarian and primary peritoneal malignancies. Gynecol Oncol. 2007;104(3):727–31. https://doi.org/10.1016/j.ygyno.2006.10.019.
Nakano J, Nakamura M. Paronychia induced by gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J Dermatol. 2003;30(3):261–2.
Kiyohara Y, Yamazaki N, Kishi A. Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. J Am Acad Dermatol. 2013;69(3):463–72. https://doi.org/10.1016/j.jaad.2013.02.025.
Rigopoulos D, Gregoriou S, Belyayeva Y, Larios G, Gkouvi A, Katsambas A. Acute paronychia caused by lapatinib therapy. Clin Exp Dermatol. 2009;34(1):94–5. https://doi.org/10.1111/j.1365-2230.2008.02928.x.
Lacouture ME, Schadendorf D, Chu CY, Uttenreuther-Fischer M, Stammberger U, O’Brien D, et al. Dermatologic adverse events associated with afatinib: an oral ErbB family blocker. Expert Rev Anticancer Ther. 2013;13(6):721–8. https://doi.org/10.1586/era.13.30.
Robert C, Sibaud V, Mateus C, Verschoore M, Charles C, Lanoy E, et al. Nail toxicities induced by systemic anticancer treatments. Lancet Oncol. 2015;16(4):e181–9. https://doi.org/10.1016/S1470-2045(14)71133-7.
Daniel CR 3rd, Iorizzo M, Piraccini BM, Tosti A. Grading simple chronic paronychia and onycholysis. Int J Dermatol. 2006;45(12):1447–8. https://doi.org/10.1111/j.1365-4632.2006.03128.x.
Daniel CR 3rd, Gupta AK, Daniel MP, Sullivan S. Candida infection of the nail: role of Candida as a primary or secondary pathogen. Int J Dermatol. 1998;37(12):904–7.
Canales FL, Newmeyer WL 3rd, Kilgore ES Jr. The treatment of felons and paronychias. Hand Clin. 1989;5(4):515–23.
Kapellen TM, Galler A, Kiess W. Higher frequency of paronychia (nail bed infections) in pediatric and adolescent patients with type 1 diabetes mellitus than in non-diabetic peers. J Pediatr Endocrinol Metab JPEM. 2003;16(5):751–8.
Stone OJ, Mullins JF. Chronic paronychia: microbiology and histopathology. Arch Dermatol. 1962;86:324–7.
Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol. 2002;47(1):73–6.
Biesbroeck LK, Fleckman P. Nail disease for the primary care provider. Med Clin North Am. 2015;99(6):1213–26. https://doi.org/10.1016/j.mcna.2015.07.010.
Baran R. Common-sense advice for the treatment of selected nail disorders. J Eur Acad Dermatol Venereol JEADV. 2001;15(2):97–102.
Rigopoulos D, Gregoriou S, Belyayeva E, Larios G, Kontochristopoulos G, Katsambas A. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol. 2009;160(4):858–60. https://doi.org/10.1111/j.1365-2133.2008.08988.x.
Keyser JJ, Eaton RG. Surgical cure of chronic paronychia by eponychial marsupialization. Plast Reconstr Surg. 1976;58(1):66–70.
Bednar MS, Lane LB. Eponychial marsupialization and nail removal for surgical treatment of chronic paronychia. J Hand Surg. 1991;16(2):314–7.
Baran R, Bureau H. Surgical treatment of recalcitrant chronic paronychias of the fingers. J Dermatol Surg Oncol. 1981;7(2):106–7.
Grover C, Bansal S, Nanda S, Reddy BS, Kumar V. En bloc excision of proximal nail fold for treatment of chronic paronychia. Dermatol Surg Off Publ Am Soc Dermatol Surg [et al.]. 2006;32(3):393–8; discussion 8–9. https://doi.org/10.1111/j.1524-4725.2006.32079.x.
Pabari A, Iyer S, Khoo CT. Swiss roll technique for treatment of paronychia. Tech Hand Up Extrem Surg. 2011;15(2):75–7. https://doi.org/10.1097/BTH.0b013e3181ec089e.
Stone OJ, Mullins JF. Chronic paronychia in children. Clin Pediatr. 1968;7(2):104–7.
Durdu M, Ruocco V. Clinical and cytologic features of antibiotic-resistant acute paronychia. J Am Acad Dermatol. 2014;70(1):120–6 e1. https://doi.org/10.1016/j.jaad.2013.09.042.
Rayan GM, Turner WT. Hand complications in children from digital sucking. J Hand Surg. 1989;14(6):933–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
13.1 Electronic Supplementary Materials
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rubin, A.I., Daniel, C.R. (2018). Acute and Chronic Paronychia. In: Rubin, A.I., Jellinek, N.J., Daniel, C.R., Scher, R.K. (eds) Scher and Daniel’s Nails. Springer, Cham. https://doi.org/10.1007/978-3-319-65649-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-65649-6_13
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65647-2
Online ISBN: 978-3-319-65649-6
eBook Packages: MedicineMedicine (R0)